Efficacy and safety of fingolimod in routine clinical practice in patients with relapsing-remitting multiple sclerosis in Spain: an intermediate analysis of the MS NEXT study

Mallada-Frechin, J; Meca-Lallana, V; Barrero Hernández, Francisco Javier; Martínez-Ginés, ML; Marzo-Sola, ME; Ricart, J; García, E

NEXT-REV-neurol 2018-autor.pdf (544.6Kb)

Identificadores

URI: https://hdl.handle.net/10481/93893

ISSN: 1576-6578

Exportar

Editorial

Viguera

Date

2018-09

Referencia bibliográfica

Mallada-Frechin J, Meca-Lallana V, Barrero F, Martinez-Gines ML, Marzo-Sola ME, Ricart J, Garcia E, En Representacion de Los Investigadores Del Estudio Ms Next ERLIDEMN. Efectividad y seguridad del fingolimod en la practica clinica habitual en pacientes con esclerosis multiple remitente recurrente en España: analisis intermedio del estudio MS NEXT [Efficacy and safety of fingolimod in routine clinical practice in patients with relapsing-remitting multiple sclerosis in Spain: an intermediate analysis of the MS NEXT study]. Rev Neurol. 2018 Sep 1;67(5):157-167. Spanish. PMID: 30047118.

Collections

DMed - Artículos

Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivatives 4.0 Internacional